Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,102 | 4,576 | 2,867 | 14,691 | 4,999 |
| Marketable Securities | 196,612 | 52,174 | 62,822 | 59,716 | 39,213 |
| Receivables | 43 | 37 | 32 | 86 | 79 |
| TOTAL | $239,946 | $58,214 | $66,944 | $75,780 | $45,491 |
| Non-Current Assets | |||||
| PPE Net | 282 | 220 | 221 | 249 | 165 |
| Investments And Advances | 10,496 | 10,991 | 11,530 | 11,794 | 12,058 |
| Other Non-Current Assets | 2,471 | 1,694 | 1,779 | 1,638 | 1,724 |
| TOTAL | $13,249 | $12,905 | $13,530 | $13,681 | $13,947 |
| Total Assets | $253,195 | $71,119 | $80,474 | $89,461 | $59,438 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,697 | 2,491 | 1,974 | 3,137 | 1,308 |
| Accrued Expenses | 6,985 | 6,486 | 5,721 | 5,013 | 3,871 |
| Other current liabilities | N/A | N/A | N/A | N/A | 3,781 |
| TOTAL | $12,110 | $9,380 | $8,074 | $8,505 | $9,279 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 406 | 534 | 632 | 728 | 834 |
| TOTAL | $406 | $534 | $632 | $728 | $834 |
| Total Liabilities | $12,516 | $9,914 | $8,706 | $9,233 | $10,113 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,090 | 83,992 | 74,682 | 74,514 | 77,115 |
| Common Shares | 8 | 7 | 7 | 7 | 7 |
| Retained earnings | -425,985 | -412,293 | -399,972 | -389,815 | -381,817 |
| Other shareholders' equity | -1,126 | -896 | -1,060 | -1,148 | -1,254 |
| TOTAL | $240,679 | $61,205 | $71,768 | $80,228 | $49,325 |
| Total Liabilities And Equity | $253,195 | $71,119 | $80,474 | $89,461 | $59,438 |